VEGFA and neoplasm: Combinations of these two drugs showed enhanced anti-angiogenic activity in non-small cell lung cancer (NSCLC) cells due to decreased VEGF levels and was evidenced by a decrease in the vessel density of NSCLC tumor xenograft samples50.